These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37503487)

  • 1. A 40-Year-Old Female With Mycobacterium abscessus Successfully Treated With a Dual Beta-Lactam Combination.
    Moguillansky N; DeSear K; Dousa KM
    Cureus; 2023 Jun; 15(6):e40993. PubMed ID: 37503487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
    Kang N; Jeon K; Kim H; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ; Jhun BW
    Chest; 2021 Aug; 160(2):436-445. PubMed ID: 33621600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease.
    Pozuelo Torres M; van Ingen J
    Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex
    Pandey R; Chen L; Manca C; Jenkins S; Glaser L; Vinnard C; Stone G; Lee J; Mathema B; Nuermberger EL; Bonomo RA; Kreiswirth BN
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Select β-Lactam Combinations Exhibit Synergy against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745389
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors.
    Dousa KM; Kurz SG; Taracila MA; Bonfield T; Bethel CR; Barnes MD; Selvaraju S; Abdelhamed AM; Kreiswirth BN; Boom WH; Kasperbauer SH; Daley CL; Bonomo RA
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393499
    [No Abstract]   [Full Text] [Related]  

  • 9. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
    Negatu DA; Zimmerman MD; Dartois V; Dick T
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0079022. PubMed ID: 36047786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Commentary: Dual β-lactam as part of regimen to treat
    Lippincott CK; Lamichhane G
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0058524. PubMed ID: 38837394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.
    van Ingen J; Totten SE; Helstrom NK; Heifets LB; Boeree MJ; Daley CL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6324-7. PubMed ID: 23027189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline].
    Wagner D; Lange C
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1145-1151. PubMed ID: 32791550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes.
    Nguyen DC; Dousa KM; Kurz SG; Brown ST; Drusano G; Holland SM; Kreiswirth BN; Boom WH; Daley CL; Bonomo RA
    Clin Infect Dis; 2021 Oct; 73(8):1532-1536. PubMed ID: 34113990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of amikacin in the treatment of nontuberculous mycobacterial disease.
    Raaijmakers J; Schildkraut JA; Hoefsloot W; van Ingen J
    Expert Opin Pharmacother; 2021 Oct; 22(15):1961-1974. PubMed ID: 34292097
    [No Abstract]   [Full Text] [Related]  

  • 16. T405, a New Penem, Exhibits
    Rimal B; Batchelder HR; Story-Roller E; Panthi CM; Tabor C; Nuermberger EL; Townsend CA; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0053622. PubMed ID: 35638855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous Mycobacteria.
    Tan S; Kasperbauer S
    Semin Respir Crit Care Med; 2021 Aug; 42(4):567-586. PubMed ID: 34261181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nontuberculous Mycobacterial Pulmonary Disease - The New ATS/ERS/ESCMID/IDSA Guideline].
    Wagner D; Lange C
    Pneumologie; 2020 Nov; 74(11):773-779. PubMed ID: 33202438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
    Daley CL; Iaccarino JM; Lange C; Cambau E; Wallace RJ; Andrejak C; Böttger EC; Brozek J; Griffith DE; Guglielmetti L; Huitt GA; Knight SL; Leitman P; Marras TK; Olivier KN; Santin M; Stout JE; Tortoli E; van Ingen J; Wagner D; Winthrop KL
    Clin Infect Dis; 2020 Aug; 71(4):905-913. PubMed ID: 32797222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.